| ARVIX | DOXFX | ARVIX / DOXFX | |
| Total Expense Ratio | 0.75 | 0.51 | 147% |
| Annual Report Gross Expense Ratio | 0.83 | 0.56 | 148% |
| Fund Existence | 5 years | 4 years | - |
| Gain YTD | 34.541 | 15.067 | 229% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250000 | 2500 | 10,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 194M | 67.8B | 0% |
| Annual Yield % from dividends | 1.68 | 2.23 | 76% |
| Returns for 1 year | 40.09 | 22.49 | 178% |
| Returns for 3 years | 85.58 | 99.17 | 86% |
| Returns for 5 years | 110.67 | N/A | - |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HLHIX | 32.78 | 0.46 | +1.42% |
| Virtus KAR Health Sciences Inst | |||
| VWNDX | 25.39 | 0.21 | +0.83% |
| Vanguard Windsor Investor Shares | |||
| GSSQX | 70.38 | 0.41 | +0.59% |
| Goldman Sachs US Equity Insights A | |||
| SGGCX | 56.13 | 0.27 | +0.48% |
| DWS Large Cap Focus Growth C | |||
| FRESX | 43.53 | N/A | N/A |
| Fidelity Real Estate Investment Port | |||